Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ ...
Months after retiring, some federal workers are stuck in a bureaucratic maze with no checks, no answers and no clear end in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results